SCHEMBL3350177

SCHEMBL3350177

CC(C)S(=O)(=O)N(C)c1cc(C(=O)O)ccn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 7/20 0.44
KDM5B Q9UGL1 7/20 0.44
KDM5A P29375 5/20 0.44
KDM5C P41229 4/20 0.44
KDM4E B2RXH2 4/20 0.44
FTO Q9C0B1 4/20 0.44
KDM4A O75164 4/20 0.44
KDM6B O15054 3/20 0.44
KDM2A Q9Y2K7 3/20 0.44
KDM3A Q9Y4C1 3/20 0.44
ALKBH5 Q6P6C2 3/20 0.44
KDM4D Q6B0I6 2/20 0.44
ALDH1A1 P00352 2/20 0.44
TET3 O43151 1/20 0.44
BBOX1 O75936 1/20 0.44
MAPT P10636 1/20 0.44
ASPH Q12797 1/20 0.44
TET2 Q6N021 1/20 0.44
KDM7A Q6ZMT4 1/20 0.44
KDM8 Q8N371 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2811985 0.81 PROKR1 (0.49) KDM4CKDM5BKDM5AKDM5CKDM4E
SCHEMBL30505322 0.81 PROKR1 (0.49) KDM4CKDM5BKDM5AKDM5CKDM4E
SCHEMBL11340185 0.77 KDM4E (0.55) KDM4CKDM5BKDM5AKDM5CKDM4E
Hydrochloric Acid SCHEMBL15973575 0.76 KDM4E (0.53) KDM4CKDM5BKDM5AKDM5CKDM4E
SCHEMBL3346038 0.75 TTR (0.35) KDM4EALDH1A1EGLN1
SCHEMBL3478647 0.73 HCAR3 (0.43) KDM4D
SCHEMBL7875993 0.73 HCAR3 (0.43) KDM4D
SCHEMBL24473745 0.72 KDM5B (0.50) KDM4CKDM5BKDM5AKDM5CKDM4E
SCHEMBL26910750 0.72 KDM4C (0.49) KDM4CKDM5BKDM5AKDM5CKDM4E
SCHEMBL21104531 0.71 KMT2A (0.46) ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010042030-A1 ASPARTYL PROTEASE INHIBITORS MEDIVIR AB (SE) 2010-04-15 WO disclosed
WO-2010042030-A1 ASPARTYL PROTEASE INHIBITORS MEDIVIR AB (SE) 2010-04-15 WO disclosed